Dimmito, M.P.; Marinelli, L.; Toto, E.C.; Di Biase, G.; Cacciatore, I.; Toto, P.; Ciulla, M.; Monti, B.; Santoleri, F.; Costantini, A.;
et al. A Methodological Proposal for Health Technology Assessments: A Case Study on Biosimilar Drugs. J. Mark. Access Health Policy 2025, 13, 12.
https://doi.org/10.3390/jmahp13020012
AMA Style
Dimmito MP, Marinelli L, Toto EC, Di Biase G, Cacciatore I, Toto P, Ciulla M, Monti B, Santoleri F, Costantini A,
et al. A Methodological Proposal for Health Technology Assessments: A Case Study on Biosimilar Drugs. Journal of Market Access & Health Policy. 2025; 13(2):12.
https://doi.org/10.3390/jmahp13020012
Chicago/Turabian Style
Dimmito, Marilisa Pia, Lisa Marinelli, Eleonora Chiara Toto, Giuseppe Di Biase, Ivana Cacciatore, Pierpaolo Toto, Michele Ciulla, Benedetta Monti, Fiorenzo Santoleri, Alberto Costantini,
and et al. 2025. "A Methodological Proposal for Health Technology Assessments: A Case Study on Biosimilar Drugs" Journal of Market Access & Health Policy 13, no. 2: 12.
https://doi.org/10.3390/jmahp13020012
APA Style
Dimmito, M. P., Marinelli, L., Toto, E. C., Di Biase, G., Cacciatore, I., Toto, P., Ciulla, M., Monti, B., Santoleri, F., Costantini, A., & Di Stefano, A.
(2025). A Methodological Proposal for Health Technology Assessments: A Case Study on Biosimilar Drugs. Journal of Market Access & Health Policy, 13(2), 12.
https://doi.org/10.3390/jmahp13020012
